scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00508-009-1161-3 |
P8608 | Fatcat ID | release_w2gnogqfbjdutbmrgfohd36fsq |
P698 | PubMed publication ID | 19562281 |
P5875 | ResearchGate publication ID | 26326357 |
P2093 | author name string | Georg A Böhmig | |
Rudolf Steininger | |||
Heinz Regele | |||
Michael Haidinger | |||
Kurt Derfler | |||
Sabine Schmaldienst | |||
Afschin Soleiman | |||
Ferdinand Mühlbacher | |||
Günther Körmöczi | |||
Dieter Schwartz | |||
P2860 | cites work | Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers | Q80418535 |
The European experience | Q80418536 | ||
Preemptive postoperative antigen-specific immunoadsorption in ABO-incompatible kidney transplantation: necessary or not? | Q80418541 | ||
On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation | Q80595531 | ||
A Comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation | Q82055056 | ||
The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy | Q83175074 | ||
ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience | Q83175081 | ||
ABO-incompatible kidney transplantation of an 8-yr-old girl with donor/recipient-constellation A1B/B | Q83175114 | ||
ABO-incompatibility in solid organ transplantation | Q34352971 | ||
Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation | Q34361643 | ||
Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease | Q34378516 | ||
ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. | Q34382354 | ||
Experiences with renal homotransplantation in the human: report of nine cases | Q35279411 | ||
B-cell tolerance following ABO-incompatible infant heart transplantation | Q36396059 | ||
Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management | Q36454167 | ||
Accommodation of grafts: implications for health and disease | Q36902090 | ||
ABO incompatible kidney transplantation | Q37035918 | ||
C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts | Q37042154 | ||
ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab - insights and uncertainties | Q37323141 | ||
Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement | Q38350904 | ||
Rapid accomodation of an A1 renal allograft after preconditioning for ABO-incompatible transplantation. | Q40028566 | ||
Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
RENAL HOMOGRAFTS IN PATIENTS WITH MAJOR DONOR-RECIPIENT BLOOD GROUP INCOMPATIBILITIES. | Q42382030 | ||
Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. | Q43931517 | ||
Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury | Q44512119 | ||
Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab | Q44584381 | ||
Does immunosuppressive pharmacotherapy affect isoagglutinin titers? | Q44977180 | ||
Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy | Q44989312 | ||
Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later. | Q45101237 | ||
ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies | Q46410666 | ||
ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up | Q46518667 | ||
ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment | Q46702772 | ||
Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression | Q46775141 | ||
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection | Q47869308 | ||
Present status of ABO-incompatible kidney transplantation in Japan. | Q51809813 | ||
Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. | Q53965909 | ||
Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from tumor necrosis factor-alpha-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. | Q54013702 | ||
Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status. | Q54586327 | ||
Present experiences in a series of 26 ABO-incompatible living donor renal allografts. | Q55060639 | ||
ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment | Q61863533 | ||
Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy. | Q64982205 | ||
Renal transplant in a patient with major donor-recipient blood group incompatibility: reversal of acute rejection by the use of modified plasmapheresis | Q70150621 | ||
Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment | Q73034296 | ||
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') | Q79921621 | ||
C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings | Q80061434 | ||
Post transplant lymphocele: a single centre experience | Q80241693 | ||
Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations | Q80318166 | ||
P433 | issue | 7-8 | |
P304 | page(s) | 247-255 | |
P577 | publication date | 2009-01-01 | |
P1433 | published in | Vienna Clinical Weekly | Q15759796 |
P1476 | title | Vienna experience of ABO-incompatible living-donor kidney transplantation | |
P478 | volume | 121 |
Q84137135 | ABO-incompatible kidney transplantation |
Q38267202 | An update on ABO-incompatible kidney transplantation |
Q36126901 | Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients |
Q54481297 | Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. |
Q43064220 | Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis |
Q38376322 | Outcome of ABO-Incompatible Living Donor Renal Transplantations: A Single-Center Experience From Eastern India |
Q27026434 | Rituximab in renal transplantation |
Q38577657 | Strategies to overcome the ABO barrier in kidney transplantation |
Q44222425 | Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation |